Nebula Research & Development LLC Madrigal Pharmaceuticals, Inc. Transaction History

Nebula Research & Development LLC

  • $852 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$146.04 - $225.78 $596,135 - $921,633
4,082 Added 165.26%
6,552 $957 Million
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $272,179 - $416,520
1,335 Added 117.62%
2,470 $571 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $262,253 - $348,535
1,135 New
1,135 $275 Million

Others Institutions Holding MDGL

# of Institutions
338
Shares Held
22.7M
Call Options Held
757K
Put Options Held
960K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email